Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - beclometasone dipropionate, quantity: 200 microgram; formoterol fumarate dihydrate, quantity: 6 microgram - inhalation, pressurised - excipient ingredients: norflurane; ethanol absolute; hydrochloric acid - asthma fostair is indicated in adults (18 years and older) in the treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids (ics) and 'as needed' inhaled rapid-acting beta2-agonist or - patients already adequately controlled on both ics and long-acting beta2-agonists (laba). (see section 4.2 dose and method of administration for treatment approaches).

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - beclometasone dipropionate, quantity: 100 microgram; formoterol fumarate dihydrate, quantity: 6 microgram - inhalation, pressurised - excipient ingredients: norflurane; ethanol absolute; hydrochloric acid - asthma fostair is indicated in adults (18 years and older) in the treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids (ics) and 'as needed' inhaled rapid-acting beta2-agonist or - patients already adequately controlled on both ics and long-acting beta2-agonists (laba). (see section 4.2 dose and method of administration for treatment approaches). copd (fostair 100/6 only) symptomatic treatment of adults with severe copd (fev1 less than 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - beclometasone dipropionate, quantity: 0.1 mg/actuation - inhalation, pressurised - excipient ingredients: ethanol; norflurane - qvar is indicated for the prophylactic management of asthma.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - beclometasone dipropionate, quantity: 0.1 mg/actuation - inhalation, pressurised - excipient ingredients: ethanol; norflurane - prophylactic management of asthma.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - beclometasone dipropionate 0.5 mg/g equivalent to beclometasone dipropionate 50 mcg per spray - nasal spray solution - 50 mcg/dose - active: beclometasone dipropionate 0.5 mg/g equivalent to beclometasone dipropionate 50 mcg per spray excipient: benzalkonium chloride dispersible cellulose glucose hydrochloric acid phenyl ethyl alcohol polysorbate 80 purified water - for short term prevention and treatment of seasonal allergic rhinitis (hayfever).

Ισραήλ - Αγγλικά - Ministry of Health

abic marketing ltd, israel - beclometasone dipropionate - inhaler - beclometasone dipropionate 50 mcg/dose - beclometasone - beclometasone - prophylaxis and treatment of bronchial asthma in adults and children 5 years of age and obove.

Ισραήλ - Αγγλικά - Ministry of Health

teva israel ltd - beclometasone dipropionate - inhaler - beclometasone dipropionate 100 mcg/dose - beclometasone - beclometasone - prophylaxis and treatment of bronchial asthma in adults and children 5 years of age and obove.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - formoterol fumarate dihydrate, quantity: 6 microgram; beclometasone dipropionate, quantity: 200 microgram; glycopyrronium bromide, quantity: 12.5 microgram (equivalent: glycopyrronium, qty microgram) - inhalation, pressurised - excipient ingredients: ethanol absolute; norflurane; dilute hydrochloric acid - asthma trimbow 200/6/10 maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.

Μάλτα - Αγγλικά - Medicines Authority

central procurement & supplies unit - beclometasone dipropionate - nasal spray, suspension - beclometasone dipropionate 50 µg - nasal preparations

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - formoterol fumarate dihydrate, quantity: 6 microgram; beclometasone dipropionate, quantity: 100 microgram; glycopyrronium bromide, quantity: 12.5 microgram (equivalent: glycopyrronium, qty 10 microgram) - inhalation, pressurised - excipient ingredients: ethanol absolute; norflurane; hydrochloric acid - copd trimbow 100/6/10 is indicated for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid (ics) and a long-acting beta2-agonist (laba) or a combination of a laba and a long-acting muscarinic antagonist (lama). asthma trimbow 100/6/10 maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.